- Home
- ALBT vs IMCC Comparison
ALBT vs IMCC Comparison
Compare ALBT & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALBT | IMCC |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 10.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALBT | IMCC |
|---|---|---|
| Price | $1.26 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 182.1K | ★ 276.3K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,611,940.00 | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $0.88 | $0.93 |
| 52 Week High | $11.66 | $7.12 |
Technical Indicators
Market Signals| Indicator | ALBT | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 42.88 |
| Support Level | $0.88 | $1.35 |
| Resistance Level | $1.40 | $1.59 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 48.42 | 8.56 |
Price Performance
Historical ComparisonAbout ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.